Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
SnackSafely.com Media Kit
SnackSafely.com Advertising Guide
Subscribe to our newsletter
Contact Us
Resources
FAQ
Partner Manufacturers
Tools for Schools
Coupons
Inspiring Food Allergy Bloggers and Authors
Search
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
SnackSafely.com Media Kit
SnackSafely.com Advertising Guide
Subscribe to our newsletter
Contact Us
Resources
FAQ
Partner Manufacturers
Tools for Schools
Coupons
Inspiring Food Allergy Bloggers and Authors
Search
Tag: Phase I Trial
Company Announces First Patient Dosing with Peanut Allergy Vaccine
News Wire ~ 3rd Party Press Release
-
2023/03/27
PROTECT Trial is evaluating the safety and tolerability of VLP Peanut.
ALK Starts Clinical Trial of SLIT Tablet to Treat Peanut Allergy
Dave Bloom
-
2022/08/17
Sublingual Immunotherapy is administered via medications placed under the tongue.
Peanut Allergy Immunotherapy Toothpaste Makes Strides Toward Phase 2 Trial
Dave Bloom
-
2022/04/06
Phase 1 study amended after two cohorts show no significant adverse events.
Aquestive’s Sublingual Epinephrine Achieves Therapeutic Blood Concentrations Following Administration
Dave Bloom
-
2022/03/01
Company presented top level Phase 1 results at #AAAAI2022 meeting.
Positive Early Results with Fecal Microbiota Therapy for Peanut-Allergic Patients
News Wire ~ 3rd Party Press Release
-
2022/02/28
Encapsulated stool from non-allergic donors alters the immune system and increases tolerance to peanuts.
Intranasal Peanut Allergy Vaccine Takes Step Forward
Dave Bloom
-
2022/02/14
Company is considering vaccines for multiple food allergies including milk, tree nuts and shellfish.
Food Allergy Toothpaste Therapy: Positive News from Ongoing Phase 1 Trial
Dave Bloom
-
2022/02/10
No significant adverse events in any patient during ongoing Phase 1 trial.
Sublingual Emergency Epinephrine Takes Another Step Forward in Phase 1 Study
Dave Bloom
-
2021/10/26
Aquestive's postage-stamp-sized film is designed to dissolve under the tongue to provide epinephrine.
Alladapt Enrolling Participants for Clinical Study of OIT Therapy to Treat...
Dave Bloom
-
2021/08/19
The study is still seeking participants 4-55 years of age.
Aquestive Charts Ambitious Path Forward for Sublingual Emergency Epinephrine
Dave Bloom
-
2021/03/26
Company updates the public on status of their candidate drug administered under the tongue.
1
2
Page 1 of 2